Terms: = Breast cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Prognosis
22 results:
1. Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer.
Adachi Y; Oze I; Sawaki M; Hattori M; Yoshimura A; Kotani H; Kataoka A; Sugino K; Horisawa N; Ozaki Y; Endo Y; Nozawa K; Takatsuka D; Iwata H
Breast Cancer; 2021 Sep; 28(5):1087-1095. PubMed ID: 33886077
[TBL] [Abstract] [Full Text] [Related]
2. Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human breast cancer.
Khan K; Safi S; Abbas A; Badshah Y; Dilshad E; Rafiq M; Zahra K; Shabbir M
Biomed Res Int; 2020; 2020():1354381. PubMed ID: 33490232
[TBL] [Abstract] [Full Text] [Related]
3. BMI1-klf4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
Hsu YC; Luo CW; Huang WL; Wu CC; Chou CL; Chen CI; Chang SJ; Chai CY; Wang HC; Chen TY; Li CF; Pan MR
Radiother Oncol; 2020 Aug; 149():249-258. PubMed ID: 32592893
[TBL] [Abstract] [Full Text] [Related]
4. Regulation of klf4 by posttranslational modification circuitry in endocrine resistance.
Zhou Z; Song X; Chi JJ; Gius DR; Huang Y; Cristofanilli M; Wan Y
Cell Signal; 2020 Jun; 70():109574. PubMed ID: 32084531
[TBL] [Abstract] [Full Text] [Related]
5. Bioinformatics analysis of potential prognostic biomarkers among Krüppel-like transcription Factors (KLFs) in breast cancer.
Cheng L; Shi L; Dai H
Cancer Biomark; 2019; 26(4):411-420. PubMed ID: 31640084
[TBL] [Abstract] [Full Text] [Related]
6. ATXN3 promotes breast cancer metastasis by deubiquitinating klf4.
Zou H; Chen H; Zhou Z; Wan Y; Liu Z
Cancer Lett; 2019 Dec; 467():19-28. PubMed ID: 31563563
[TBL] [Abstract] [Full Text] [Related]
7. A novel small-molecule antagonizes PRMT5-mediated klf4 methylation for targeted therapy.
Zhou Z; Feng Z; Hu D; Yang P; Gur M; Bahar I; Cristofanilli M; Gradishar WJ; Xie XQ; Wan Y
EBioMedicine; 2019 Jun; 44():98-111. PubMed ID: 31101597
[TBL] [Abstract] [Full Text] [Related]
8. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
Saha SK; Jeong Y; Cho S; Cho SG
Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
[TBL] [Abstract] [Full Text] [Related]
9. Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced breast cancer Stem Cell Enrichment.
Lu H; Tran L; Park Y; Chen I; Lan J; Xie Y; Semenza GL
Cancer Res; 2018 Aug; 78(15):4191-4202. PubMed ID: 29880481
[TBL] [Abstract] [Full Text] [Related]
10. klf4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer.
Jia Y; Zhou J; Luo X; Chen M; Chen Y; Wang J; Xiong H; Ying X; Hu W; Zhao W; Deng W; Wang L
Cell Signal; 2018 Jan; 42():165-175. PubMed ID: 28988130
[TBL] [Abstract] [Full Text] [Related]
11. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
[TBL] [Abstract] [Full Text] [Related]
12. klf4 and NANOG are prognostic biomarkers for triple-negative breast cancer.
Nagata T; Shimada Y; Sekine S; Moriyama M; Hashimoto I; Matsui K; Okumura T; Hori T; Imura J; Tsukada K
Breast Cancer; 2017 Mar; 24(2):326-335. PubMed ID: 27300169
[TBL] [Abstract] [Full Text] [Related]
13. klf4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth.
Hu W; Jia Y; Xiao X; Lv K; Chen Y; Wang L; Luo X; Liu T; Li W; Li Y; Zhang C; Yu Z; Huang W; Sun B; Deng WG
Oncotarget; 2016 Aug; 7(33):52870-52887. PubMed ID: 27153563
[TBL] [Abstract] [Full Text] [Related]
14. Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231.
De Blasio A; Di Fiore R; Morreale M; Carlisi D; Drago-Ferrante R; Montalbano M; Scerri C; Tesoriere G; Vento R
Int J Oncol; 2016 Jun; 48(6):2339-48. PubMed ID: 27082853
[TBL] [Abstract] [Full Text] [Related]
15. Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.
Ferrer I; Verdugo-Sivianes EM; Castilla MA; Melendez R; Marin JJ; Muñoz-Galvan S; Lopez-Guerra JL; Vieites B; Ortiz-Gordillo MJ; De León JM; Praena-Fernandez JM; Perez M; Palacios J; Carnero A
Oncogene; 2016 May; 35(21):2777-88. PubMed ID: 26387546
[TBL] [Abstract] [Full Text] [Related]
16. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.
Sun LL; Wu JY; Wu ZY; Shen JH; Xu XE; Chen B; Wang SH; Li EM; Xu LY
Int J Cancer; 2015 Mar; 136(6):E569-77. PubMed ID: 25220908
[TBL] [Abstract] [Full Text] [Related]
17. Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence.
Finicelli M; Benedetti G; Squillaro T; Pistilli B; Marcellusi A; Mariani P; Santinelli A; Latini L; Galderisi U; Giordano A
Oncotarget; 2014 Oct; 5(20):9678-88. PubMed ID: 25127259
[TBL] [Abstract] [Full Text] [Related]
18. The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model.
Yin B; Ma ZY; Zhou ZW; Gao WC; Du ZG; Zhao ZH; Li QQ
Oncogene; 2015 Feb; 34(6):761-70. PubMed ID: 24531713
[TBL] [Abstract] [Full Text] [Related]
19. A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
Elsir T; Edqvist PH; Carlson J; Ribom D; Bergqvist M; Ekman S; Popova SN; Alafuzoff I; Ponten F; Nistér M; Smits A
Int J Cancer; 2014 Mar; 134(5):1123-31. PubMed ID: 24037901
[TBL] [Abstract] [Full Text] [Related]
20. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating klf4.
Okuda H; Xing F; Pandey PR; Sharma S; Watabe M; Pai SK; Mo YY; Iiizumi-Gairani M; Hirota S; Liu Y; Wu K; Pochampally R; Watabe K
Cancer Res; 2013 Feb; 73(4):1434-44. PubMed ID: 23384942
[TBL] [Abstract] [Full Text] [Related]
[Next]
